Thus, the modulation of NFκB activity could represent an useful therapeutic strategy for cancer, since NFκB inhibition promotes apoptotic events induced by chemotherapy, reduces the high proliferative rate that characterizes tumour cells and inhibits metastasis [134]. The gene discussed is NFKB1; the disease is cancer.